Teladoc (TDOC) Up 22% In A Year: Will The Rally Continue?
Zacks Investment Research | Jun 18, 2019 09:08PM ET
Teladoc Health, Inc. (NYSE:TDOC) shares have been in favor with investors by virtue of its consistent top-line growth, increasing subscriptions and visits.
This has led the stock to gain 23% in a year’s time compared with its industry ’s rise of 4%.
Teladoc is one of the few listed companies with a leading market share in the burgeoning telehealth market. The company has been continuously navigating in the domestic as well as overseas telehealth market through mergers and acquisitions.
Teladoc is fast gaining ground in the rapidly growing telehealth services industry in the United States, with ample scope for flourishing, owing to rising health care costs following inefficient care, duplication of services, significant waste and extreme variation in access, cost and quality of care.
Moreover, Teladoc has the capability to address this inefficiency by providing superior quality of care through platform that caters to consumer demand and physician availability in real-time and in various modalities such as video, web, mobile and telephone. The emergence of technology, via big data and analytics, cloud-based solutions, online video and mobile applications, also offers the company with huge opportunity for growth.
Teladoc’s strategy to complement its organic growth with inorganic means is commendable. The acquisitions of HealthiestYou, Best Doctors, Advance Medical have increased the breadth of its business. The latest acquisition of Advance Medical has given it a global exposure, which should enable it to harness the international markets.
A report by Medgadget says that Global Telehealth Market is expected to grow at a healthy CAGR of 29.8% by 2023. Teladoc is one of the few companies that should gain from the global demand for telehealth, given its acquisition of Advance Medical, which has expanded the company’s business in Latin America and Asia. Advance Medical allows Teladoc to deliver care in 125 countries in more than 120 languages.
The company has also formed a virtual care service called Teladoc Global Care, with infrastructural support from the recent acquisitions of Advance Medical and Best Doctors. This new platform has enabled to offer its services globally, which was until now restricted within the United States.
We expect the company’s Global Care platform to attract huge traction as employers and insurers demand international services for telehealth, due to growing number of expatriates.
We thus expect the company’s revenues to be aided by increased business from international operations, while its U.S. business is already doing well. The company’s strong growth is expected to keep the rally in the shares alive.
Teladoc, carrying a Zacks Rank #3 (Hold), has gained 39% year to date, compared with the industry’s growth of 9%.
Get The News You Want
Some better-ranked stocks in the same space are HealthEquity, Inc. (NASDAQ:HQY) , ICON PLC (NASDAQ:ICLR) and Premier, Inc. (NASDAQ:PINC) . Each of these stocks carries a Zacks Rank #2 (Buy). You can see Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.